Biotech · Private company · Elkridge, MD, US
Evon Medics LLC
Track this companyFree. Adds Evon Medics LLC to your Dealase workspace and tells you when its record changes.
Clinical trials50 recruiting or active
Pipeline programs12From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline12
- CBOT + TAUPhase 2 · Opioid Use Disorder, ModerateClinicalTrials.gov · fetched Nov 12, 2026
- CBOT ShamPhase 2 · Substance Use DisordersClinicalTrials.gov · fetched Nov 12, 2026
- CBOT with olfactory stimulants & OFC tasksPhase 2 · Substance Use DisordersClinicalTrials.gov · fetched Nov 12, 2026
- Computerized Chemosensory-Based Orbitofrontal Cortex Training (CBOT)Phase 2 · Chronic PainClinicalTrials.gov · fetched Nov 12, 2026
- Computerized Chemosensory-Based Orbitofrontal Cortex Training for PainPhase 2 · Chronic PainClinicalTrials.gov · fetched Nov 12, 2026
- COTPhase 2 · Mild Cognitive ImpairmentClinicalTrials.gov · fetched Nov 12, 2026
- EDITOR (CBOT with olfactory stimulants, OFC tasks & remote monitoring of treatment compliance)Phase 2 · Substance Use DisordersClinicalTrials.gov · fetched Nov 12, 2026
- ShamPhase 2 · Mild Cognitive ImpairmentClinicalTrials.gov · fetched Nov 12, 2026
- Sham + TAUPhase 2 · Opioid Use Disorder, ModerateClinicalTrials.gov · fetched Nov 12, 2026
- Computerized Chemosensory-Based Orbitofrontal Cortex Training (CBOT) long burst paradigmPhase 1 · Chronic PainClinicalTrials.gov · fetched Nov 12, 2026
- Computerized Chemosensory-Based Orbitofrontal Cortex Training (CBOT) short burst paradigmPhase 1 · Chronic PainClinicalTrials.gov · fetched Nov 12, 2026
- Computerized Chemosensory-Based Orbitofrontal Cortex Training plus beta caryophyllene (CBOT-Plus)Phase 1 · Chronic PainClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials5
- Development and Evaluation of Computerized Chemosensory-Based Orbitofrontal Networks Training for Treatment of Pain (CBOT-P)PHASE2 · UNKNOWN · started Oct 23, 2024ClinicalTrials.gov NCT06671132 · fetched Nov 12, 2026
- Enhanced Digital-Chemosensory-Based Olfactory Training for Remote Management of Substance Use DisordersPHASE2 · UNKNOWN · started Jul 7, 2023ClinicalTrials.gov NCT06434818 · fetched Nov 12, 2026
- Development and Evaluation of Computerized Chemosensory Based Orbitofrontal Networks Training for Treatment of PainPHASE1 · COMPLETED · started Apr 27, 2023ClinicalTrials.gov NCT06218407 · fetched Nov 12, 2026
- Development and Evaluation of Computerized Olfactory Training Program for Cognitive Decline in Early Alzheimer's DiseasePHASE2 · UNKNOWN · started Nov 15, 2021ClinicalTrials.gov NCT05122598 · fetched Nov 12, 2026
- Computerized Chemosensory-Based Orbitofrontal Cortex (CBOT) for Opioid Use DisorderPHASE2 · UNKNOWN · started Mar 26, 2021ClinicalTrials.gov NCT04850664 · fetched Nov 12, 2026
NIH awards5
- Development and Evaluation of Portable Compendium of Psychophysical and Physiological Tests for Alzheimer's Disease and Related Dementias (ADRD)Fiscal year 2025 · $1.2MNIH RePORTER 5R44AG082621-03 · fetched Nov 12, 2026
- Development and Evaluation of Computerized Chemosensory-Based Orbitofrontal Networks Training for Treatment of Pain (CBOT-P)Fiscal year 2025 · $1.3MNIH RePORTER 5R44NS125745-03 · fetched Nov 12, 2026
- Development and Evaluation of Portable Compendium of Psychophysical and Physiological Tests for Alzheimer's Disease and Related Dementias (ADRD)Fiscal year 2024 · $1.2MNIH RePORTER 4R44AG082621-02 · fetched Nov 12, 2026
- Development and Evaluation of Computerized Chemosensory-Based Orbitofrontal Networks Training for Treatment of Pain (CBOT-P)Fiscal year 2024 · $1.3MNIH RePORTER 4R44NS125745-02 · fetched Nov 12, 2026
- The Development and Evaluation of Enhanced Digital-Chemosensory-Based Olfactory Training for Remote Management of Substance Use Disorders (EDITOR)Fiscal year 2024 · $1.2MNIH RePORTER 5R44DA056156-03 · fetched Nov 12, 2026